Monitoring spasticity in multiple sclerosis using smart technology
Official title: Smart Monitoring Assessing Spasticity-related Health - A Prospective Multiple Sclerosis Study With Wearables
Run by Heinrich-Heine University, Duesseldorf · NCT06937723 · Data updated 2026-11-12
This study is testing if using smartwatches to track symptoms can help people with multiple sclerosis better understand and manage their spasticity over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 1 site (Düsseldorf, North Rhine-Westphalia) |
| Status | Recruiting |
| Started | October 19, 2023 |
| Main results expected | July 2025 |
| Study ends | September 2025 |
| Registry record updated | April 22, 2025 |
| Trial ID | NCT06937723 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of multiple sclerosis and moderate to severe spasticity requiring medical treatment.
✕Probably not a fit
Patients with significant comorbidities affecting their ability to understand or complete the study may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates spasticity in patients with multiple sclerosis (MS) through multimodal monitoring techniques. By integrating digital biomarkers from smartwatches with clinical assessments, the study aims to evaluate the effectiveness of these digital measurements in monitoring everyday limitations caused by spasticity. Approximately 50 patients will be followed over three visits, every 12 weeks, to gather comprehensive data on their symptoms and treatment responses. The goal is to enhance understanding of spasticity and improve treatment monitoring.
Why it matters
Potential benefit: If successful, this study could lead to better management of spasticity in MS patients through more accurate monitoring and tailored treatments.
How similar studies have gone: While the use of digital health tools in monitoring conditions like MS is emerging, this specific multimodal approach is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients must meet all the following criteria to be eligible to participate in the study: * ≥ 18 years of age * Diagnosis of multiple sclerosis according to the McDonald criteria of 2017 * Presence of spasticity that requires medical treatment from a medical point of view * own and use a smartphone with Android 8.1 (or higher version) or iOS 12.3 (or higher version) * Able to operate a smartphone Exclusion Criteria: * Missing informed consent * Lack of declaration of consent * Unwillingness or inability to use the smartphone app * Any comorbidity that leads to impaired understanding or successful completion of the study, such as (but not limited to) psychiatric comorbidities or dementia. The decision will be made at the discretion of the investigators.
Where it's running
-
Medical Faculty, Heinrich-Heine-University
Düsseldorf, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Study coordinator: Marc Pawlitzki, PD Dr. med.
- Email: neuro-trials@med.uni-duesseldorf.de
- Phone: 0049 21181-17889
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.